 Home > Active Ingredient News > Antitumor Therapy > The UK MHRA has issued a positive opinion on the early treatment of lutetium (177Lu) vipivotide tetraxetan in prostate cancer

The UK MHRA has issued a positive opinion on the early treatment of lutetium (177Lu) vipivotide tetraxetan in prostate cancer

 Last Update: 2022-05-18
 Source: Internet
 Author: User

Tags

sloppy stage 2

1 2 4 triazole

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Advanced prostate cancer kills over 11,500 people each year in the UK alone

Advanced Accelerator Applications (AAA), a Novartis pharmaceutical company, has announced that eligible patients with advanced prostate cancer in the UK have been approved for early-stage radioligand therapy

Lutetium (177Lu) vipivotide tetraxetan is a radioconjugate composed of PSMA-617, a human prostate-specific membrane antigen (PSMA) targeting ligand, bound to the beta-emitting radioisotope lutetium (177Lu) with antitumor activity

The decision to approve lutetium(177Lu) vipivotide tetraxetan was supported by an international, prospective, open-label, multicenter, randomized, phase III study (VISION; NCT03511664)

At a median follow-up of 20.

The median OS was 15.

Original source:

https:// href="https://" target="_blank" rel="noopener">https:// https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Desmethyl Imatinib 99%

CAS No.: 404844-02-6

Pharma Grade

$1/MT FOB

Topotecan HCl CAS 119413-54-6 for Scientific Research Chemical Reagents Use only topetecan hydrochloride

CAS No.: 119413-54-6

Pharmacy Grade

$4-5/G FOB

Regorafenib 98% white powder 755037-03-7 Regorafenib (BAY 73-4506)

CAS No.: 755037-03-7

Pharmacy Grade

$4-5/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.